Increasing Public Awareness and Provider Education about Primary Immunodeficiency Disease

 

The purpose of the program is to strengthen the nations capacity to carry out public health activities in the area of primary immunodeficiency diseases (PID) by increasing and improving physician education and public health awareness for/of PID. The intent is to disseminate educational information on a national level to health care providers, educators, third-party payers, impacted families, and others who may help expedite clinical recognition and improve health outcomes for Americans with primary immunodeficiency diseases.

Active 93.980 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. 317(k)(2) of Public Health Service Act, 42 USC 247 b (K)(2), 12372 Applicants with experience in: conducting effective physician education and public awareness campaigns for primary immunodeficiency diseases, collaborating effectively with health care and public health partners, and maximizing resources dedicated to campaign materials development and distribution to meet outcome goals. The general public will benefit from outcome of this program. Refer to the Notice of Funding Opportunity for requirements. Preapplication coordination is not applicable. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. July 20, 2017 to July 19, 2022 Contact the headquarters or regional location, as appropriate for application deadlines From 90 to 120 days. Not applicable. Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. Applicants will be evaluated on the review criteria described in the NOFO. See the NOFO for additional details. Financial Assistance will not be used for research activities. Funding for this grant will be used to reduce the burden of primary immunodeficiency diseases. Funding for activities should be allocated per the strategy to best meet the short, medium, and long term outcome goals. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award None/Not specified. Scott Bowen
1600 Clifton Road
Altanta, GA 30329 US
sbowen1@cdc.gov
Phone: 404-498-0068
Fax: 404-498-0140

Salaria Allen
1600 Clifton Rd, NE
Mailstop H21-8
Atlanta, GA 30333 USA
gwh8@cdc.gov
Phone: 404-498-6043 http://WWW.CDC.GOV 75-0959-0-1-550 (Project Grants) FY 22$2,800,000.00; FY 23 est $2,800,000.00; FY 24 est $2,800,000.00; FY 21$2,800,000.00; FY 20$1,904,500.00; - The range and average award is $921, 500. Not applicable. Not applicable.